Quality of reporting internal and external validity data from randomized controlled trials evaluating stents for percutaneous coronary intervention

被引:17
作者
Ethgen, Morgane [1 ,2 ,3 ,4 ]
Boutron, Isabelle [1 ,2 ,3 ,4 ]
Steg, Philippe Gabriel [1 ,2 ,3 ,4 ]
Roy, Carine [1 ,2 ,3 ,4 ]
Ravaud, Philippe [1 ,2 ,3 ,4 ]
机构
[1] INSERM, U738, Paris, France
[2] Univ Paris 07, UFR Med, Paris, France
[3] Hop Bichat Claude Bernard, AP HP, Dept Epidemiol Biostat & Rech Clin, F-75877 Paris, France
[4] INSERM, U698, Paris, France
关键词
ELEVATION-MYOCARDIAL-INFARCTION; VOLUME-OUTCOME RELATION; ASSOCIATION TASK-FORCE; AMERICAN-COLLEGE; GUIDELINE UPDATE; OPERATOR VOLUME; CLINICAL-TRIALS; ANGIOPLASTY; MANAGEMENT; COMMITTEE;
D O I
10.1186/1471-2288-9-24
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Stents are commonly used to treat patients with coronary artery disease. However, the quality of reporting internal and external validity data in published reports of randomised controlled trials (RCTs) of stents has never been assessed. The objective of our study was to evaluate the quality of reporting internal and external validity data in published reports of RCTs assessing the stents for percutaneous coronary interventions. Methods: A systematic literature review was conducted. Reports of RCTs assessing stents for percutaneous coronary interventions indexed in MEDLINE and the Cochrane Central Register of Controlled Trials and published between January 2003 and September 2008 were selected. A standardized abstraction form was used to extract data. All analyses were adjusted for the effect of clustering articles by journal. Results: 132 articles were analyzed. The generation of the allocation sequence was adequate in 58.3% of the reports; treatment allocation was concealed in 34.8%. Adequate blinding was reported in one-fifth of the reports. An intention-to-treat analysis was described in 79.5%. The main outcome was a surrogate angiographic endpoint in 47.0%. The volume of interventions per center was described in two reports. Operator expertise was described in five (3.8%) reports. The quality of reporting was better in journals with high impact factors and in journals endorsing the CONSORT statement. Conclusion: The current reporting of results of RCTs testing stents needs to be improved to allow readers to appraise the risk of bias and the applicability of the results.
引用
收藏
页数:9
相关论文
共 33 条
[1]   The revised CONSORT statement for reporting randomized trials: Explanation and elaboration [J].
Altman, DG ;
Schulz, KF ;
Moher, D ;
Egger, M ;
Davidoff, F ;
Elbourne, D ;
Gotzsche, PC ;
Lang, T .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (08) :663-694
[2]   Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials [J].
Balk, EM ;
Bonis, PAL ;
Moskowitz, H ;
Schmid, CH ;
Ioannidis, JPA ;
Wang, CC ;
Lau, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (22) :2973-2982
[3]   A checklist to evaluate a report of a nonpharmacological trial (CLEAR NPT) was developed using consensus [J].
Boutron, I ;
Moher, D ;
Tugwell, P ;
Giraudeau, B ;
Poiraudeau, S ;
Nizard, R ;
Ravaud, P .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2005, 58 (12) :1233-1240
[4]   Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials [J].
Boutron, I ;
Tubach, F ;
Giraudeau, B ;
Ravaud, P .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2004, 57 (06) :543-550
[5]   Methodological differences in clinical trials evaluating nonpharmacological and pharmacological treatments of hip and knee osteoarthritis [J].
Boutron, I ;
Tubach, F ;
Giraudeau, B ;
Ravaud, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (08) :1062-1070
[6]   Strategies for reducing the door-to-balloon time in acute myocardial infarction [J].
Bradley, Elizabeth H. ;
Herrin, Jeph ;
Wang, Yongfei ;
Barton, Barbara A. ;
Webster, Tashonna R. ;
Mattera, Jennifer A. ;
Roumanis, Sarah A. ;
Curtis, Jeptha P. ;
Nallamothu, Brahmajee K. ;
Magid, David J. ;
McNamara, Robert L. ;
Parkosewich, Janet ;
Loeb, Jerod M. ;
Krumholz, Harlan M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (22) :2308-2320
[7]   ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-Segment elevation myocardial infarction - Summary article - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina) [J].
Braunwald, E ;
Antman, EM ;
Beasley, JW ;
Califf, RM ;
Cheitlin, MD ;
Hochman, JS ;
Jones, RH ;
Kereiakes, D ;
Kupersmith, J ;
Levin, TN ;
Pepine, CJ ;
Schaeffer, JW ;
Smith, EE ;
Steward, DE ;
Theroux, P ;
Gibbons, RJ ;
Alpert, JS ;
Faxon, DP ;
Fuster, V ;
Gregoratos, G ;
Hiratzka, LF ;
Jacobs, AK ;
Smith, SC .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (07) :1366-1374
[8]   Need for expertise based randomised controlled trials [J].
Devereaux, PJ ;
Bhandari, M ;
Clarke, M ;
Montori, VM ;
Cook, DJ ;
Yusuf, S ;
Sackett, DL ;
Cinà, CS ;
Walter, SD ;
Haynes, B ;
Schünemann, HJ ;
Norman, GR ;
Guyatt, GH .
BMJ-BRITISH MEDICAL JOURNAL, 2005, 330 (7482) :88-91
[9]   Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials [J].
Ferreira-Gonzalez, I. ;
Busse, J. W. ;
Heels-Ansdell, D. ;
Montori, V. M. ;
Akl, E. A. ;
Bryant, D. M. ;
Alonso, J. ;
Jaeschke, R. ;
Schuenemann, H. J. ;
Permanyer-Miralda, G. ;
Domingo-Salvany, A. ;
Guyatt, G. H. .
BMJ-BRITISH MEDICAL JOURNAL, 2007, 334 (7597) :786-788A
[10]   Composite outcomes in randomized trials - Greater precision but with greater uncertainty? [J].
Freemantle, N ;
Calvert, M ;
Wood, J ;
Eastaugh, J ;
Griffin, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (19) :2554-2559